<DOC>
	<DOC>NCT02001545</DOC>
	<brief_summary>RE-ACT is a national, multi-centre, observational, prospective, longitudinal cohort study which will include patients hospitalized for ACS within 24 hours of symptom onset and who have a final diagnosis of ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation myocardial infarction (NSTEMI). This study aims to describe the short-term (at the end of the first month after index event) antithrombotic management patterns in a "real-life" setting for patients hospitalized with an acute coronary syndrome.</brief_summary>
	<brief_title>REal World Information on Cardiovascular Drug Management Patterns in Acute Coronary Syndrome paTients</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Acute Coronary Syndrome</mesh_term>
	<criteria>Provision of subject informed consent Patients hospitalized and diagnosed with STEMI or NSTEMI Hospitalized within 24 hours of onset of symptoms or transferred from another hospital within 24 hours of the onset of symptoms STEMI and NSTEMI precipitated by or as a complication of surgery, trauma, or GI bleeding or postPCI. STEMI and NSTEMI occurring in patients already hospitalized for other reasons. Presence of any condition/circumstance which in the opinion of the investigator could significantly limit the complete follow up of the patient (e.g. tourist, nonnative speaker or does not understand the local language, psychiatric disturbances).</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2014</verification_date>
	<keyword>acute coronary syndrome, antithrombotic management patterns,quality of life, acute clinical management strategies</keyword>
</DOC>